61 Results

People

  1. Perales
    Perales
  2. Giralt
    Giralt
  3. Hsu
    Hsu
  4. Jakubowski
    Jakubowski
  5. Papadopoulos
    Papadopoulos
  6. Sauter
    Sauter
  7. Young
    Young
  8. O'Reilly
    O'Reilly
  9. Shah
    Shah
  10. Castro-Malaspina
    Castro-Malaspina

Groups

  1. Bone Marrow Transplant (61)
  2. Center for Hematologic Malignancies (61)
  3. Department of Medicine (61)
  4. Hematologic Malignancies Research (61)
  5. Hematologic Malignancies, Division of (61)
  6. Survivorship Research (61)
  7. GSK Faculty (56)
  8. Sloan Kettering Institute Faculty (40)
  9. Epidemiology and Biostatistics (38)
  10. Biostatistics Service (35)
  1. "Hematologic Malignancies Research"
  2. "Miguel-Angel Perales"
  3. "Survivorship Research"
Formats
  1. Meeting Abstract (37)
  2. Journal Article (24)
Groups
  1. Bone Marrow Transplant (61)
  2. Center for Hematologic Malignancies (61)
  3. Department of Medicine (61)
  4. Hematologic Malignancies Research (61)
  5. Hematologic Malignancies, Division of (61)
  6. Survivorship Research (61)

More Groups

People
  1. Miguel-Angel Perales (61)
  2. Sergio Giralt (38)
  3. Ann Jakubowski (33)
  4. Katharine Hsu (33)
  5. Craig Sauter (32)
  6. Esperanza Papadopoulos (32)

More People

Years
  1. 2023 (2)
  2. 2021 (5)
  3. 2020 (11)
  4. 2019 (10)
  5. 2018 (3)
  6. 2017 (3)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (24)
  2. Blood (23)
  3. Blood Advances (4)
  4. Bone Marrow Transplantation (3)
  5. British Journal of Haematology (1)
  6. Clinical Lymphoma, Myeloma and Leukemia (1)

More Publications

Publishers
  1. American Society of Hematology (27)
  2. Elsevier Inc. (25)
  3. Nature Publishing Group (5)
  4. American Society for Clinical Investigation (1)
  5. Elsevier Science, Inc. (1)
  6. John Wiley & Sons (1)

More Publishers

Results (61)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2
    Meeting Abstract

    Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: Phase 2 trial interim results
    Journal Article

    Park, J. H.; Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G.; Dahi, P.; Lin, R. J.; Scordo, M.; Perales, M. A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Silverman, E. A.; Hubbeling, H.; Palomba, M. L.; Wijetunga, N. A.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy
    Meeting Abstract

    Hubbeling, H.; Silverman, E. A.; Wijetunga, N. A.; Palomba, M. L.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
    Journal Article

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J. R.; Shouval, R.; Alarcon Tomas, A.; Silverberg, M. L.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Devlin, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin
    Journal Article

    Politikos, I.; Devlin, S. M.; Arcila, M. E.; Barone, J. C.; Maloy, M. A.; Naputo, K. A.; Ruiz, J. D.; Mazis, C. M.; Scaradavou, A.; Avecilla, S. T.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: A multicenter observational study
    Journal Article

    Khan, N.; Lindner, S.; Gomes, A. L. C.; Devlin, S. M.; Shah, G. L.; Sung, A. D.; Sauter, C. S.; Landau, H. J.; Dahi, P. B.; Perales, M. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • International prognostic index predicts outcomes in patients with relapsed and refractory large diffuse B cell lymphoma treated with commercial CAR T cells
    Meeting Abstract

    Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Roni, S.; Batlevi, Y.; Silverberg, M. L.; Batlevi, C. W.; Brentjens, R.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
    Journal Article

    Barker, J. N.; Devlin, S. M.; Naputo, K. A.; Skinner, K.; Maloy, M. A.; Flynn, L.; Anagnostou, T.; Avecilla, S. T.; Scaradavou, A.; Cho, C.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Prognostic factors for postrelapse survival after ex vivo CD34(+)-selected (T cell-depleted) allogeneic hematopoietic cell transplantation in multiple myeloma
    Journal Article

    Gomez-Arteaga, A.; Shah, G. L.; Baser, R. E.; Scordo, M.; Ruiz, J. D.; Bryant, A.; Dahi, P. B.; Ghosh, A.; Lahoud, O. B.; Landau, H. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save